Autres langues Azenta, Inc.

Actions

AZTA

US1143401024

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 28/07/2026			Varia. 5j.	Varia. 1 janv.
28,93 ^USD	+5,12%		+8,80%	-13,02%

07/05	AZENTA, INC. : Needham & Co. toujours à l'achat	ZM
06/05	Transcript : Azenta, Inc., Q2 2026 Earnings Call, May 06, 2026

Autres langues

22/07	Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast
14/07	Artisan Industries Appoints Stephen Schwartz and Gary Doyon to Board of Directors
08/07	Azenta Completes Sale of B Medical Systems
29/06	Azenta, Inc.(NasdaqGS:AZTA) added to Russell 2000 Value-Defensive Index
29/06	Azenta, Inc.(NasdaqGS:AZTA) added to Russell 2000 Defensive Index
21/05	Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
06/05	Azenta : Presentation (Q2 26 Earnings Deck FINAL 05 05 26)
06/05	Azenta : Press Release (Q2 26 Earnings Release 05 05 26)
06/05	Azenta : Supplemental Information (Q2 26 Earnings Supplemental Letter 05 05 26)
05/05	Earnings Flash (AZTA) Azenta, Inc. Reports Q2 Revenue $145.0M, vs. FactSet Est of $148.5M
05/05	Earnings Flash (AZTA) Azenta, Inc. Posts Q2 Adjusted Loss $0.04 per Share
05/05	Tranche Update on Azenta, Inc.'s Equity Buyback Plan announced on December 10, 2025.
05/05	Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
05/05	Azenta, Inc. Reports Impairment Charges for the Second Quarter Ended March 31, 2026
05/05	Azenta, Inc. Provides Earnings Guidance for the Fiscal Year Ending September 30, 2026
05/05	Azenta, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026
29/04	Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast
07/04	Azenta, Inc. Announces Executive Changes
07/04	Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
02/04	Azenta says Thelema has not secured financing deal did not close by March 31, 2026 - SEC filing
04/03	Azenta Acquires UK Biocentre for $27.4 Million
04/03	Azenta completes strategic acquisition of UK Biocentre Limited, to expand biorepository capabilities
04/03	Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
24/02	Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference
09/02	Azenta Teams Up With Frontier Space for Space-Based Scientific Experiments